FDA Adverse Event Malfunction Summary report: N

ISE INDIRECT K+ FOR GEN.2

MDR report key: 2163026 · Received July 15, 2011

Report

Report Number
1823260-2011-03753
Event Type
Malfunction
Date Received
July 15, 2011
Date of Event
June 16, 2011
Report Date
August 31, 2011
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CEM
PMA / PMN Number
K060373
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

FURTHER INVESTIGATION DETERMINED THE ROOT CAUSE FOR THE ISSUE COULD BE A BAD CALIBRATION. AFTER REPLACEMENT OF THE REFERENCE ELECTRODE AND RECALIBRATION, THE ISSUE APPEARED TO BE RESOLVED. AS ADDITIONAL DATA WAS NOT PROVIDED, FURTHER INVESTIGATION WAS NOT POSSIBLE.

Additional Manufacturer Narrative · 1

OTHER ASSAYS RELATED TO THIS EVENT ARE REPORTED IN MEDWATCH REPORT WITH PATIENT IDENTIFIER: (B)(6).

Description of Event or Problem · 1

THE USER RECEIVED QUESTIONABLE ION SELECTIVE ELECTRODE-POTASSIUM RESULTS FOR OVER 100 PATIENT SAMPLES FROM THE COBAS 8000 ISE MODULE SERIAL NUMBER (B)(4). OF THE DATA PROVIDED, THE RESULTS FOR 53 PATIENT SAMPLES WERE DISCREPANT. THE REPEAT TESTING WAS PERFORMED ON A COBAS 6000 ANALYZER. ALL RESULTS ARE IN MMOL/L. PATIENT SAMPLE 1 INITIAL RESULT WAS 4.7 AND THE REPEAT RESULT WAS 5.2. PATIENT SAMPLE 2 INITIAL RESULT WAS 4.7 AND THE REPEAT RESULT WAS 5.2. PATIENT SAMPLE 3 INITIAL RESULT WAS 3.6 AND THE REPEAT RESULT WAS 4.1. PATIENT SAMPLE 4 INITIAL RESULT WAS 5.1 AND THE REPEAT RESULT WAS 5.6. PATIENT SAMPLE 5 INITIAL RESULT WAS 4.5 AND THE REPEAT RESULT WAS 5.0. PATIENT SAMPLE 6 INITIAL RESULT WAS 3.6 AND THE REPEAT RESULT WAS 4.1. PATIENT SAMPLE 7 INITIAL RESULT WAS 4.1 AND THE REPEAT RESULT WAS 4.6. PATIENT SAMPLE 8 INITIAL RESULT WAS 3.6 AND THE REPEAT RESULT WAS 4.1. PATIENT SAMPLE 9 INITIAL RESULT WAS 3.8 AND THE REPEAT RESULT WAS 4.3. PATIENT SAMPLE 10 INITIAL RESULT WAS 3.8 AND THE REPEAT RESULT WAS 4.3. PATIENT SAMPLE 11 INITIAL RESULT WAS 3.5 AND THE REPEAT RESULT WAS 5.3. PATIENT SAMPLE 12 INITIAL RESULT WAS 3.7 AND THE REPEAT RESULT WAS 4.2. PATIENT SAMPLE 13 INITIAL RESULT WAS 4.2 AND THE REPEAT RESULT WAS 4.7. PATIENT SAMPLE 14 INITIAL RESULT WAS 4.2 AND THE REPEAT RESULT WAS 4.7. PATIENT SAMPLE 15 INITIAL RESULT WAS 3.6 AND THE REPEAT RESULT WAS 4.1. PATIENT SAMPLE 16 INITIAL RESULT WAS 3.7 AND THE REPEAT RESULT WAS 4.4. PATIENT SAMPLE 17 INITIAL RESULT WAS 3.9 AND THE REPEAT RESULT WAS 4.4. PATIENT SAMPLE 18 INITIAL RESULT WAS 5.1 AND THE REPEAT RESULT WAS 5.6. PATIENT SAMPLE 19 INITIAL RESULT WAS 3.7 AND THE REPEAT RESULT WAS 4.2. PATIENT SAMPLE 20 INITIAL RESULT WAS 3.6 AND THE REPEAT RESULT WAS 4.2. PATIENT SAMPLE 21 INITIAL RESULT WAS 3.9 AND THE REPEAT RESULT WAS 4.4. PATIENT SAMPLE 22 INITIAL RESULT WAS 4.3 AND THE REPEAT RESULT WAS 4.8. PATIENT SAMPLE 23 INITIAL RESULT WAS 4.4 AND THE REPEAT RESULT WAS 4.9. PATIENT SAMPLE 24 INITIAL RESULT WAS 3.8 AND THE REPEAT RESULT WAS 4.3. PATIENT SAMPLE 25 INITIAL RESULT WAS 4.0 AND THE REPEAT RESULT WAS 4.5. PATIENT SAMPLE 26 INITIAL RESULT WAS 4.1 AND THE REPEAT RESULT WAS 4.6. PATIENT SAMPLE 27 INITIAL RESULT WAS 3.9 AND THE REPEAT RESULT WAS 4.5. PATIENT SAMPLE 28 INITIAL RESULT WAS 4.6 AND THE REPEAT RESULT WAS 5.1. PATIENT SAMPLE 29 INITIAL RESULT WAS 3.7 AND THE REPEAT RESULT WAS 4.2. PATIENT SAMPLE 30 INITIAL RESULT WAS 4.3 AND THE REPEAT RESULT WAS 4.8. PATIENT SAMPLE 31 INITIAL RESULT WAS 3.8 AND THE REPEAT RESULT WAS 4.3. PATIENT SAMPLE 32 INITIAL RESULT WAS 5.3 AND THE REPEAT RESULT WAS 5.8. PATIENT SAMPLE 33 INITIAL RESULT WAS 3.7 AND THE REPEAT RESULT WAS 4.2. PATIENT SAMPLE 34 INITIAL RESULT WAS 3.9 AND THE REPEAT RESULT WAS 4.4. PATIENT SAMPLE 35 INITIAL RESULT WAS 3.1 AND THE REPEAT RESULT WAS 3.7. PATIENT SAMPLE 36 INITIAL RESULT WAS 3.9 AND THE REPEAT RESULT WAS 4.5. PATIENT SAMPLE 37 INITIAL RESULT WAS 3.7 AND THE REPEAT RESULT WAS 4.2. PATIENT SAMPLE 38 INITIAL RESULT WAS 3.6 AND THE REPEAT RESULT WAS 4.1. PATIENT SAMPLE 39 INITIAL RESULT WAS 3.7 AND THE REPEAT RESULT WAS 4.3. PATIENT SAMPLE 40 INITIAL RESULT WAS 3.9 AND THE REPEAT RESULT WAS 4.5. PATIENT SAMPLE 41 INITIAL RESULT WAS 3.4 AND THE REPEAT RESULT WAS 4.0. PATIENT SAMPLE 42 INITIAL RESULT WAS 4.0 AND THE REPEAT RESULT WAS 4.7. PATIENT SAMPLE 43 INITIAL RESULT WAS 4.9 AND THE REPEAT RESULT WAS 5.4. PATIENT SAMPLE 44 INITIAL RESULT WAS 4.3 AND THE REPEAT RESULT WAS 4.8. PATIENT SAMPLE 45 INITIAL RESULT WAS 4.4 AND THE REPEAT RESULT WAS 4.9. PATIENT SAMPLE 46 WAS FROM A (B)(6) MALE. THE INITIAL RESULT WAS 4.7 AND THE REPEAT RESULT WAS 5.2 (5.15 WITH A DATA FLAG). PATIENT SAMPLE 47 INITIAL RESULT WAS 4.3 AND THE REPEAT RESULT WAS 4.9 (4.88). PATIENT SAMPLE 48 INITIAL RESULT WAS 4.7 AND THE REPEAT RESULT WAS 5.4 (5.36 WITH A DATA FLAG). PATIENT SAMPLE 49 INITIAL RESULT WAS 3.2 AND THE REPEAT RESULT WAS 3.8 (3.78). PATIENT SAMPLE 50 INITIAL RESULT WAS 3.6 AND THE REPEAT RESULT WAS 4.1 (4.12). PATIENT SAMPLE 51 INITIAL RESULT WAS 4.2 AND THE REPEAT RESULT WAS 4.7 (4.65). PATIENT SAMPLE 52 INITIAL RESULT WAS 4.0 AND THE REPEAT RESULT WAS 4.5 (4.47). PATIENT SAMPLE 53 INITIAL RESULT WAS 3.7 AND THE REPEAT RESULT WAS 4.1 (4.11). THE INITIAL RESULTS WERE REPORTED OUTSIDE THE LABORATORY AND CORRECTED RESULTS WERE SENT FOR ABOUT 100 SAMPLES. NONE OF THE PATIENTS WERE TREATED OR ADVERSELY AFFECTED BASED ON THE ERRONEOUS RESULTS. THE PATIENT FOR SAMPLE 46 WAS INSTRUCTED TO GO TO THE ER BUT ENDED UP NOT GOING SINCE HIS GENERAL PRACTITIONER REQUESTED HE COME IN THE FOLLOWING MORNING AND BE REDRAWN. UPON EVALUATION OF THE ANALYZER, THE FIELD SERVICE REPRESENTATIVE DETERMINED THE CAUSE WAS THE REFERENCE ELECTRODE AND REPLACED IT. TO VERIFY THE ANALYZER OPERATION, THE USER RAN CALIBRATION AND QUALITY CONTROL WITH RESULTS THAT MET THE LABORATORY'S SPECIFICATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ISE INDIRECT K+ FOR GEN.2 ELECTRODE, ION SPECIFIC, POTASSIUM CEM ROCHE DIAGNOSTICS NA R87

Patients

Seq Age Sex Outcome Treatment
1